Double Medical Technology Inc. (SHE:002901)
China · Delayed Price · Currency is CNY 43.20
+0.50 (1.17%)
Aug 4, 2026, 3:04 PM CST
Double Medical Technology Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,692 | 2,601 | 2,136 | 1,533 | 1,434 | 1,994 |
Revenue Growth | 19.19% | 21.79% | 39.30% | 6.91% | -28.09% | 25.68% |
Gross Profit Gross Profit Growth | 1,867 | 1,775 | 1,425 | 991.6 | 1,089 | 1,675 |
Operating Income Operating Income Growth | 643.86 | 571.15 | 332.5 | 19.47 | 30.9 | 717.45 |
Net Income Net Income Growth | 643.1 | 599.63 | 356.8 | 58.96 | 92.56 | 673.31 |
Earnings Per Share EPS Growth | 1.58 | 1.47 | 0.86 | 0.14 | 0.22 | 1.67 |
EPS Growth | 64.89% | 70.93% | 514.29% | -36.36% | -86.83% | 10.60% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Trauma Product Trauma Product Growth | 998.52 | 842.2 | 572.37 | 542.45 | 1,128 |
Spine Product Spine Product Growth | 493.13 | 394.33 | 283.67 | 472.1 | 565.38 |
Minimally Invasive Surgery Products Minimally Invasive Surgery Products Growth | 408.9 | 368.78 | 286.64 | 191.6 | 149.63 |
Joint Products Joint Products Growth | 252.18 | 202.54 | 156.32 | 58.61 | 21.45 |
Neurosurgical Products Neurosurgical Products Growth | 114.35 | 82.44 | 81.48 | 46.99 | 43.82 |
Dental Products Dental Products Growth | 71.13 | 65.84 | 52.26 | 24.76 | - |
Other Products Other Products Growth | 262.65 | 179.43 | 67.14 | 74.05 | 60.97 |
Total Total Growth | 2,601 | 2,136 | 1,533 | 1,434 | 1,989 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,840 | 1,749 | 1,249 | 1,661 | 1,351 | 1,221 |
Total Debt Total Debt Growth | 359.98 | 315.87 | 385.68 | 600.2 | 69.17 | 21.06 |
Net Cash (Debt) Net Cash Growth | 1,480 | 1,434 | 863.01 | 1,061 | 1,282 | 1,200 |
Net Cash Growth | 69.35% | 66.11% | -18.65% | -17.26% | 6.83% | 9.37% |
Net Cash Per Share Net Cash Per Share Growth | 3.64 | 3.51 | 2.08 | 2.52 | 3.05 | 2.98 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 875.77 | 831.34 | 442.3 | 73.89 | 128.44 | 673.26 |
Capital Expenditures CapEx Growth | -144.66 | -133.51 | -270.46 | -305.72 | -285.07 | -235.11 |
Free Cash Flow Free Cash Flow Growth | 731.11 | 697.83 | 171.84 | -231.82 | -156.63 | 438.15 |
Free Cash Flow Growth | 249.88% | 306.09% | - | - | - | 4.66% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 69.36% | 68.23% | 66.75% | 64.68% | 75.97% | 84.00% |
Operating Margin | 23.92% | 21.96% | 15.57% | 1.27% | 2.15% | 35.97% |
Pretax Margin | 29.21% | 28.07% | 20.06% | 6.50% | 10.28% | 40.24% |
Profit Margin | 23.89% | 23.05% | 16.71% | 3.85% | 6.45% | 33.76% |
FCF Margin | 27.16% | 26.83% | 8.05% | -15.12% | -10.92% | 21.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.600 | 0.600 | 0.500 | 0.250 | - | 0.500 |
Dividend Per Share Growth | 20.00% | 20.00% | 100.00% | - | - | -37.50% |
Dividend Yield | 1.39% | 1.28% | 1.66% | 0.64% | - | 1.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 27.00 | 32.12 | 35.25 | 285.02 | 151.93 | 30.17 |
Forward PE | 25.57 | 32.84 | 33.07 | 38.02 | 15.42 | 60.69 |
P/FCF Ratio | 23.87 | 27.60 | 73.20 | - | - | 46.36 |
PS Ratio | 6.48 | 7.41 | 5.89 | 10.96 | 9.81 | 10.18 |